000 04006nam a22004455i 4500
001 978-1-59259-881-6
003 DE-He213
005 20161121230555.0
007 cr nn 008mamaa
008 100301s2005 xxu| s |||| 0|eng d
020 _a9781592598816
_9978-1-59259-881-6
024 7 _a10.1385/1592598811
_2doi
050 4 _aRD598.5-598.7
072 7 _aMNJ
_2bicssc
072 7 _aMED085050
_2bisacsh
082 0 4 _a617.413
_223
245 1 0 _aLower Extremity Arterial Disease
_h[electronic resource] /
_cedited by Dennis G. Caralis, George L. Bakris.
264 1 _aTotowa, NJ :
_bHumana Press,
_c2005.
300 _aXIII, 306 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aClinical Hypertension and Vascular Diseases
505 0 _aClaudication -- Noninvasive Diagnostic Evaluation of Peripheral Arterial Disease -- Smoking and Smoking Cessation -- Peripheral Arterial Disease and Diabetes -- Hyperlipidemia in Peripheral Arterial Disease -- Hypertension and Peripheral Vascular Disease -- Physical Inactivity is a Risk Factor for Lower Extremity Arterial Disease and Coronary Heart Disease -- Pathogenesis of Atherosclerotic Vascular Disease -- Lower Extremity Arterial Disease Co-Existing With Coronary Artery Disease -- Medical Therapy of Claudication and Lower Extremity Arterial Disease -- Exercise Therapy for Lower Extremity Arterial Disease -- Endovascular Strategies for Management of Claudication and Lower Extremity Arterial Disease -- Severe Lower Extremity Arterial Disease.
520 _aAlthough associated with coronary heart disease and generalized arteriosclerosis in a large number of patients, lower extremity arterial disease (LEAD) is a disease process by itself that only one in four patients will survive more than 10 years. Approximately 10 million men and women in the United States suffer from LEAD. In Lower Extremity Arterial Disease, leaders in the fields of cardiovascular medicine, hypertension, vascular surgery, vascular radiology, and vascular physiology join forces to comprehensively review the state-of-the-art concerning atherosclerosis of the arteries of the legs and feet. The authors discuss in detail LEAD's primary symptom-claudication-an intermittent pain in the leg or foot while walking, its predisposing factors, the current diagnostic methodologies, the impressive advances in the therapeutic armamentarium, and the need to screen for co-existing coronary artery disease. Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug-eluting stents for peripheral arterial disease. The authors also examine the epidemiology of LEAD, the effects of smoking and effective smoking cessation programs, its pathogenesis and its association with lipid abnormalities and hypertension, aggressive risk factor modification, and the need to measure the ankle-brachial index of every patient over 45. Authoritative and up-to-date, Lower Extremity Arterial Disease offers family physicians, cardiologists, internists, radiologists, and cardiovascular surgeons a comprehensive analysis of all aspects of LEAD, ranging from diagnostic methodologies and pharmacotherapy to aggressive risk factor modification, transcatheter therapeutics, and gene therapy.
650 0 _aMedicine.
650 0 _aVascular surgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aVascular Surgery.
700 1 _aCaralis, Dennis G.
_eeditor.
700 1 _aBakris, George L.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781588295545
830 0 _aClinical Hypertension and Vascular Diseases
856 4 0 _uhttp://dx.doi.org/10.1385/1592598811
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c500766
_d500766